What changes?
Until now, medtech companies or industry research institutes could apply for the award themselves. In future, the selection process will be more targeted. For the Swiss Medtech Award 2023, we are creating a nomination committee consisting of seven people whose networks collectively encompass all regions of Switzerland. One member will be an expert familiar with the start-up scene. The nomination committee will undertake the initial pre-selection and choose which companies to submit for jury appraisal.
The nominated companies must also fulfil formal and objective criteria to be eligible to present their achievements to the jury. The winning team is announced at Swiss Medtech Day and receives prize money valued at CHF 75,000. Reserve now to attend this interesting event on 13 June 2023.
You too can participate: if you would like to nominate a company or a research group for the competition, please do not hesitate to contact the Swiss Medtech representative.
Who can be nominated?
Nomination criteria
Candidates selected by the nominating partners must meet the following criteria.
Official criteria
All three official criteria must be fully met.
- Medical Technology Sector
The companies, their products and solutions must be active in the medical technology industry. - Market success
Candidates must prove that the goods or services provided have already found success on the market. - «Swissness» factor
The achievements and provision of services must have been developed to a significant extent within Switzerland.
Factual criteria
At least one of the following factual criteria must be met.
- Proven patient benefit
A new product or product line with significant patient benefits has already been launched. - Provision of Health care
Public healthcare has been advanced through pioneering, groundbreaking, and innovative technologies or processes. - Entrepreneurial achievement
Outstanding entrepreneurial performance has been achieved in the recent past.
award Process
The following steps are part of the evaluation process. The nominees are asked to save the dates.
Upcoming steps
The shortlisted candidates each present their achievements to the jury.
The winner will be announced and present their innovation live on stage during Swiss Medtech Day, Switzerland's most important medical technology conference.
NominatiNG partners
Peter Biedermann
Member of the nomination committee
Director
Swiss Medtech
Magali Bischof
Member of the nomination committee
Secretary General
BioAlps Association
Hans Ebinger
Member of the nomination committee
CEO
Switzerland Innovation Park Ost
Lukas Huber
Member of the nomination committee
Deputy Managing Director
Greater Zurich Area Ltd.
Christoph Lang
Member of the nomination committee
Managing Director
ITZ InnovationsTransfer Zentralschweiz
Giuseppe Perale
Member of the nomination committee
Executive VP & Founder I.B.I. SA
Regenera SA
Katrin Siebenbürger Hacki
Member of the nomination committee
Director
Medows GmbH
Jury
Prof Dr Mirko Meboldt
President of the Jury
Chair of Product Development
& Engineering
ETH Zurich
Hans Ulrich Lehmann
Member of the Jury
Senior Vice President Technology
Ypsomed
Stephan Oehler
Member of the Jury
Head of Technology & Testing
Straumann
Sabina Sperisen
Member of the Jury
CEO
Lichtsteiner Foundation
Andi Vonlanthen
Member of the Jury
Group Vice President R&D
Sonova Holding
Donors
The Lichtsteiner Foundation helps pioneers bring their inventions to life by investing in early stage start-ups in the fields of medical technology, life science, mental health, public health and wellbeing. The foundation focuses on impact investing by providing funding in the form of equity.
Sonova, headquartered in Stäfa is a leading provider of innovative hearing care solutions. The group operates through its core business brands Phonak, Unitron, Hansaton, Advanced Bionics and AudioNova. We reach our consumers through multiple channels; this diversity lets them benefit from our broad range of solutions – hearing aids, cochlear implants, wireless communication products, eSolutions, and professional audiological care – in the way that best suits their individual needs.
Founded in 1947, the Group has a workforce of over 14,000 dedicated employees. Across all businesses, and by supporting the Hear the World Foundation, Sonova pursues its vision of a world where everyone enjoys the delight of hearing and therefore lives a life without limitations.
The Straumann Group is a global leader in tooth replacement and orthodontic solutions that restore smiles and confidence. It unites global and international brands that stand for excellence, innovation and quality in replacement, corrective and digital dentistry, including Anthogyr, ClearCorrect, Dental Wings, Medentika, Neodent, NUVO, Straumann and other fully/partly owned companies and partners. In collaboration with leading clinics, institutes and universities, the Group researches, develops, manufactures and supplies dental implants, instruments, CADCAM prosthetics, biomaterials and digital solutions for use in tooth replacement and restoration or to prevent tooth loss.
With over 30 years’ experience, the Ypsomed Group is a renowned diabetes specialist and principle developer and manufacturer of injection and infusion systems for self-medication. As a leader in innovation and technology, Ypsomed is the preferred partner of pharmaceutical and biotech companies for the supply of injections pens, autoinjectors and infusion systems which administer liquid drugs. Ypsomed promotes its product portfolio under the following umbrella brands: mylife Diabetescare sells directly to patients or via pharmacies and clinics, and YDS Ypsomed Delivery Systems deals business-to-business with pharmaceutical companies.
About Swiss Medtech Award
In 2018, Swiss Medtech launched the Swiss Medtech Award together with the prize sponsors Lichtsteiner Foundation, Straumann Group and Ypsomed. The award recognizes outstanding achievements in the Swiss medical technology industry. In 2021, the Sonova Group could be won as a fourth award sponsor. Jointly with the others, they agreed to raise the prize money to 75.000 Swiss francs as of 2022.
The prize is awarded once a year to a carefully selected winner that has convinced the jury, chaired by Prof. Mirko Meboldt, ETH Zurich, in a two-stage evaluation process. The criteria assessed by the jurors are patient benefit, contribution to improving healthcare, and technological pioneering spirit. The winning team will be announced and celebrated at Swiss Medtech Day, the most important event for the Swiss medical technology industry.
